GLP-3 R 15mg
Triple agonist research peptide studied for coordinated GLP-1, GIP, and glucagon receptor signaling in metabolic pathway models.
Compound Overview
GLP-3 R is a triple agonist research peptide evaluated in laboratory environments for its interaction with glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptor pathways. Compounds in this category are studied for their coordinated effects across multiple metabolic signaling systems.
In controlled research models, triple agonist peptides are commonly examined for receptor-binding dynamics, downstream intracellular signaling, and integrated endocrine pathway activity. Investigations often focus on metabolic regulation models, energy-balance signaling, and the relationship between incretin and glucagon-associated mechanisms.
Receptor Activity
Studied for coordinated activity at GLP-1, GIP, and glucagon receptors within multi-pathway metabolic research systems.
Metabolic Research Focus
Commonly evaluated in laboratory studies involving endocrine signaling, incretin pathway interaction, and energy-regulation mechanisms.
Laboratory Classification
Classified as a triple agonist peptide for experimental and analytical research applications.
Product Specifications
- Product Name: GLP-3 R
- Peptide Type: Triple agonist research peptide
- Target Pathways: GLP-1, GIP, and glucagon receptor signaling
- Quantity: 15mg per vial
- Form: Lyophilized peptide powder
- Intended Use: Research use only
Be the first to review “GLP-3 R 15MG”
Related products
Reviews
There are no reviews yet.